Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation
Open Access
- 29 June 2017
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (8) , 2315-2329
Abstract
Despite frequent herpes simplex virus (HSV) reactivation, peripheral nerve destruction and sensory anesthesia are rare. We discovered that skin biopsies obtained during asymptomatic human HSV-2 reactivation exhibit a higher density of nerve fibers relative to biopsies during virological and clinical quiescence. We evaluated the effects of HSV infection on keratinocytes, the initial target of HSV replication, to better understand this observation. Keratinocytes produced IL-17c during HSV-2 reactivation, and IL-17RE, an IL-17c–specific receptor, was expressed on nerve fibers in human skin and sensory neurons in dorsal root ganglia. In ex vivo experiments, exogenous human IL-17c provided directional guidance and promoted neurite growth and branching in microfluidic devices. Exogenous murine IL-17c pretreatment reduced apoptosis in HSV-2–infected primary neurons. These results suggest that IL-17c is a neurotrophic cytokine that protects peripheral nerve systems during HSV reactivation. This mechanism could explain the lack of nerve damage from recurrent HSV infection and may provide insight to understanding and treating sensory peripheral neuropathies.Keywords
Funding Information
- National Institutes of Health (R01 AI042528, R01 AI111780, PO1 AI030731)
- James B. Pendleton Charitable Trust
- National Institutes of Health (5R24HD000836)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health (AI063106)
This publication has 41 references indexed in Scilit:
- Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infectionNature, 2013
- Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tracteLife, 2013
- Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trialsThe Lancet, 2012
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor EImmunity, 2011
- Recent advances in the IL-17 cytokine familyCurrent Opinion in Immunology, 2011
- Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodesProceedings of the National Academy of Sciences, 2010
- Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionNature Medicine, 2009
- Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 2009
- Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivationJournal of Experimental Medicine, 2007
- Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cellsProceedings of the National Academy of Sciences, 2006